Article
Study of protein targets for covalent modification by the antitumoral and anti-inflammatory prostaglandin PGA1: focus on vimentin.
Journal of mass spectrometry : JMS - 1 Nov 2007
Gharbi Severine, Garzón Beatriz, Gayarre Javier, Timms John, Pérez-Sala Dolores
Abstract excerpt
Prostaglandins with cyclopentenone structure (cyPG) display potent antiproliferative actions that have elicited their study as potential anticancer agents. Several natural and synthetic analogs of the cyPG prostaglandin A(1) (PGA(1)) have proven antitumoral efficacy in cancer cell lines and animal models. In addition, PGA(1) has been used as an inhibitor of transcription factor NF-kappaB-mediated processes,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
